DUBLIN–(BUSINESS WIRE)–The “Gout
– Global Clinical Trial Pipeline Highlights, 2019” report has
been added to ResearchAndMarkets.com’s offering.
This report provides most up-to-date information on key pipeline
products in the global Gout market. It covers emerging therapies for
Gout in active clinical development stages including early and late
stage clinical trials.
The pipeline data presented in this report helps executives for tracking
competition, identifying partners, evaluating opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.
Clinical Trial Stages
The report provides Gout pipeline products by clinical trial stages
including both early and late stage development – phase 3 clinical
trials, phase 2 clinical trials, phase 1 clinical trials, preclinical
research, and discovery stage.
Drug Mechanism Classes
The report provides Gout pipeline products by their dominant mechanism
of action/drug class. This helps executives categorize products based on
their drug class and also assess the strengths and weaknesses of
compounds.
Company
The report provides Gout pipeline products by the company.
Short-term Launch Highlights
Find out which Gout pipeline products will be launched in the US and
Ex-US till 2024.
Key Topics Covered
1. Gout Pipeline by Stages
2. Gout Phase 3 Clinical Trial Insights
3. Gout Phase 2 Clinical Trial Insights
4. Gout Phase 1 Clinical Trial Insights
5. Gout Preclinical Research Insights
6. Gout Discovery Stage Insights
7. Appendix
8. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/r/i0kqq4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Immune
Disorders Drugs, Clinical
Trials, Endocrine
and Metabolic Disorders Drugs, Musculoskeletal
Disorders Drugs